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Pathways and Genes Associated 
with Immune Dysfunction in Sheep 
Paratuberculosis
Anton Gossner1, Craig Watkins2, Francesca Chianini2 & John Hopkins1
Multibacillary and paucibacillary paratuberculosis are both caused by Mycobacterium avium subspecies 
paratuberculosis. Multibacillary lesions are composed largely of infected epithelioid macrophages 
and paucibacillary lesions contain T cells but few bacteria. Multibacillary disease is similar to human 
lepromatous leprosy, with variable/high levels of antibody and a dysfunctional immune response. 
Animals with paucibacillary disease have high cell-mediated immunity and variable levels of antibody. 
This study aims to characterize the immunological dysfunction using TruSeq analysis of the ileocaecal 
lymph node that drains disease lesions. Immune dysfunction is highlighted by repression of TCR/CD3 
genes, T cell co-receptors/co-stimulators, T cell activation and signal-transduction genes. Inflammation 
was an acute phase response and chronic inflammation, with little evidence of acute inflammation. 
The high levels of immunoglobulin and plasma cell transcripts is consistent with the anti-MAP 
antibody responses in paratuberculosis sheep. Also notable was the overwhelming reduction in mast 
cell transcripts, potentially affecting DC activation of the immune response. This study also shows 
that there were no fundamental differences in the gene expression patterns in multibacillary and 
paucibacillary disease, no shift in T cell genes from Th1 to Th2 pattern but rather an incremental decline 
into immune dysfunction leading to multibacillary pathology.
Mycobacterium avium subspecies paratuberculosis (MAP) is the causative agent of paratuberculosis or Johne’s 
disease1. This is an enteric disease of ruminants and an endemic problem for livestock worldwide2–5. MAP is an 
intracellular bacterium, typically infecting macrophages of the small intestine, with severe lesions often occurring 
in the terminal ileum6–8. As with human tuberculosis and leprosy, only a minority of infected individuals develop 
clinical pathology, and infection results in a spectrum of disease forms6,9 graded by a range of pathological char-
acteristics. Similarities in the pathology of paratuberculosis with leprosy have led to the broad classification of 
these disease forms in sheep as paucibacillary (tuberculoid) and multibacillary (lepromatous)6,7. Paucibacillary 
(P) lesions consist largely of T cells and Langhan’s giant cells but few bacteria; in contrast multibacillary (M) 
lesions are characterized by heavily-infected epithelioid macrophages10,11. It is this form of the disease that is most 
problematic in relation to the dissemination of infection because of the high numbers of mycobacteria in faeces12 
and milk11,13.
The different cell infiltrates of P and M lesions are likely to be linked to the contrasting immune responses 
associated with the two disease forms. This is manifest by variable levels of anti-MAP antibody with high cell 
mediated immunity (CMI) in P pathology and often high levels of antibody and low CMI in M disease14,15. 
Studies on lesion tissue in sheep with advanced disease have linked P pathology with a Th1 response and high lev-
els of IFNγ that controls bacterial growth; and M disease with Th2 activation, low IFNγ levels and consequently 
uncontrolled bacterial replication10,15,16. A similar dichotomy of polarized responses is seen with the progression 
from P to M pathology in cattle17,18 and in human tuberculosis and leprosy19,20. However, recent studies have 
cast doubt on the hypothesis that discrimination of P and M disease is simply a matter of a Th1 to Th2 switch21. 
Macrophages are the target cells for MAP1,22 with infection influencing their metabolism and transcriptome23,24. 
They also have a central role in the activation and polarization of T cells. MAP infection-associated changes to 
antigen processing pathways23, cytokine and innate receptor expression25–27 are also likely to play a role in the 
development of the two disease forms.
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Experimental infection studies in both cattle28–30 and sheep21 have linked progression to M disease with T cell 
dysfunction that results in the loss of CMI, T cell unresponsiveness and exhaustion. Studies on the molecular 
nature of the reduced T cell function in bovine paratuberculosis have identified increased expression of immu-
noinhibitory molecules in the suppression of anti-MAP T cell responses in vitro30, and shown a reduction in 
expression of the T cell receptor second messenger ZAP7031.
Previous transcriptome studies on paratuberculosis had the broad aim of describing the effects of MAP infec-
tion on host gene expression. Studies in cattle and red deer examined in vitro infected macrophages24,32,33, blood 
leukocytes34,35 and the ileocaecal valve36 from infected animals. A recent project focussed on lymph node from 
experimentally-infected red deer with no defined pathology37. Investigations of the disease in sheep have largely 
focussed on lesions38,39 with the consequent difficulties of differentiating cause and effect, although lymph node 
and blood analyses have also been performed39. These studies showed that immune-mediated genes and path-
ways were associated with paratuberculosis pathologies. The immunological events that lead to the development 
of the different pathological forms of paratuberculosis are unlikely to occur within the gastrointestinal mucosa, 
but within the lymph nodes that drain that tissue40. Macrophages and dendritic cells (DC) may be the first cells 
to respond to intracellular infection but the host immune response will primarily be under T cell regulation. This 
current study used Illumina TruSeq to analyse the transcriptome of the Ileocaecal lymph node (ICLN), the major 
immune-inductive site for the terminal ileum; to investigate the immune and inflammatory responses associated 
with P and M disease, focussing on the nature of the immune dysfunction in M paratuberculosis.
Results
Diagnosis of multibacillary and paucibacillary paratuberculosis. Animals with M and P lesions 
were identified on the basis of: clinical signs, bacteriology and gross pathology, haematoxylin and eosin 
(H&E) and Ziehl-Neelsen (ZN) histopathology of terminal ileum and mesenteric lymph node (MLN) (see 
Supplementary Table S1). M lesions were composed largely of heavily-infected epithelioid macrophages; P 
lesions were composed largely of lymphocytes, with few ZN+ bacteria. Infected animals were culture and inser-
tion sequence 900 (IS900) positive; amplicon sequences were identical to MAP IS900 (accession no. S74401.1). 
Uninfected controls (C) were all were IS900 negative.
Analysis of the ICLN transcriptome. TruSeq analysis of the ICLN of sheep with M and P paratuberculosis 
and uninfected C (n = 5 for each group) obtained an average of 56,080,477 paired-end reads (101 bp) per sample 
library and mapping efficiencies of 74.27% to 87.85% (see Supplementary Table S2). Reads were mapped to the 
Ovis aries genome assembly OAR3.1 and the relationships in expression profiles between samples were explored 
using multidimensional scaling (MDS) plot (see Supplementary Figure S1). The plot showed that the paratu-
berculosis samples were more heterogeneous than C; however there was clear separation along dimension 1 of 
infected and C samples. Differential expression analysis between groups using linear models fitted to the data-
sets revealed 4,852 differentially-expressed genes (DEG) in M vs. C, 2,761 in P vs. C and 62 in M vs. P (adjusted 
p-value ≤ 0.05) comparisons. The volcano plots of the M vs. C and P vs. C comparisons show a symmetrical 
distribution of up-regulated and down-regulated genes, although the absolute fold changes were generally higher 
for up-regulated genes (see Supplementary Figure S1).
The twenty most up-regulated and down-regulated genes in the M vs. C and P vs. C comparisons are listed 
in Tables 1 and 2. The most up-regulated transcript in M sheep was pentraxin PTX3 (+ 280.38 fold); SAA1  
(+ 48.93 fold) and FGF23 (+ 36.69 fold) were also highly increased. The most up-regulated transcript in P sheep 
was PROC (+ 67.62 fold); others included seven immunoglobulin genes comprising IGHG1 (+ 15.62 fold) and 
IGHE (+ 13.25 fold) and five light chain genes (average + 11.64 fold). The most down-regulated transcripts in the 
M and P datasets were HDC (M, − 54.25 and P, − 10.6 fold) and GPR143 (M, − 35.25 and P, − 33.27 fold) respec-
tively. A spreadsheet of all the DEG can be found as Supplementary Table S3.
Comparison of multibacillary and paucibacillary disease. Of the forty most DEG in M sheep 
(Table 1) and P sheep (Table 2), eighteen were common to both. Common genes included XDH (M, + 84.49 and 
P, + 14.07 fold), and the calcium binding proteins S100A8 (M, + 179.69 and P, + 49.01 fold) and S100A12 (M, 
+ 99.72 fold and P, + 27.02 fold). S100A2 (+10.19 fold) and S100A9 (+ 5.50 fold) were also significantly raised 
in M, but not in P. The mast cell specific transcripts HDC and CPA3 (M, − 41.73 and P, − 6.63 fold) were highly 
repressed genes common to both disease pathologies. Additional mast cell transcripts down-regulated in both 
datasets were TPSAB1 (M, − 22.24 and P, − 5.21 fold), FCER1A (M, − 21.36 and P, − 3.72 fold), KIT (M, − 2.69 and 
P, − 2.51 fold) and KITLG (M, − 2.44 and P, − 2.47 fold) (see Supplementary Table S3). Preliminary observations 
of toluidine blue histology shows many more mast cells in the ICLN of uninfected C sheep than in M animals (see 
Supplementary Figure S2); the number of mast cells are similar in M and P.
Spearman’s correlation analysis of fold changes of the top genes (Tables 1 and 2) identified a significant corre-
lation (Spearman’s rs 0.79, p < 0.0001) between M and P sheep. This high level of similarity reflects the fact that 
there were only 62 significant DEG in the comparison of the M and P datasets (see Supplementary Table S3); none 
was affected in the opposite direction in the two disease forms. The two most up-regulated genes in the M vs. 
P comparison were CYP4F11 (+ 29.5 fold) and VNN1 (+ 17.69 fold), and the most down-regulated (annotated) 
gene was CD40LG (− 2.7 fold).
Ingenuity pathway analysis. The functional classification of 1,097 annotated DEG (fold change ≥ 2; 
adjusted p-value ≤ 0.05) in the M dataset, by Ingenuity pathway analysis (IPA), identified a significant enrichment 
of genes in canonical pathways mostly associated with T cell immunity/activation, and inflammation and tissue 
repair (Fig. 1). Similar analysis with the 481 annotated DEG in the P dataset also identified pathways associated 
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with inflammation and tissue repair, but did not identify a significant enrichment of genes linked with the adap-
tive immune response (see Supplementary Figure S3).
Disease-associated changes to the T cell transcriptome. Of the top twenty canonical pathways iden-
tified in the M dataset seven were associated with adaptive immunity. The majority of identified genes within 
these pathways were repressed. All thirty-four identified TCR genes in the ‘T cell receptor signalling’ pathway 
were repressed including transcripts of the alpha/beta (average − 2.92 fold) and gamma/delta chains (average 
− 2.40 fold). Transcripts of all four identified CD3 genes (average − 2.07 fold) and the TCR/CD3 signalling path-
way members LCK (− 2.99 fold), FYN (− 1.48 fold), ZAP70 (− 2.66 fold) and LAT (− 2.68 fold) were significantly 
reduced (Fig. 2). Within the other T cell pathways, repressed genes included; TCR co-receptors CD4 (− 1.57 fold); 
CD8A (− 2.33 fold) and CD8B (− 2.28 fold), T cell co-stimulators CD28 (− 2.62 fold), ICOS (− 2.35 fold) and 
CD40LG (− 1.94 fold); and the T cell activation marker CD69 (− 2.01 fold). The lymphocyte surface markers CD5 
(− 2.48 fold) and CD6 (− 2.92 fold) were also repressed as were the protein kinase C molecules, PRKCB, PRKCE, 
PRKCG, PRKCH and PRKCQ (average − 2.24 fold). Not all T cell genes were down-regulated; CD70 was increased 
Ensembl id Gene
P-value FC P-value FC
Multi vs control Pauci vs control
ENSOARG00000002754 PTX3 0.0031 280.38 0.0628 35.25
ENSOARG00000000450 S100A8 0.0025 179.69 0.0253 49.01
ENSOARG00000004127 FOLR1 0.0016 173.01 0.3852 4.51
ENSOARG00000000432 S100A12 0.0012 99.72 0.0188 27.02
ENSOARG00000010953 XDH 0.0007 84.49 0.0355 14.07
ENSOARG00000004536 RPL17 0.0001 56.06 0.0072 10.26
ENSOARG00000009847 SAA1 0.0001 48.93 0.0136 10.09
ENSOARG00000014440 VNN1 0.0002 40.23 0.3848 2.27
ENSOARG00000010198 FGF23 0.0053 36.69 0.3494 3.89
ENSOARG00000016105 PROC 0.0010 35.20 0.0010 67.62
ENSOARG00000002862 CD163 0.0002 33.82 0.0303 4.56
ENSOARG00000009608 RNF186 0.0056 33.48 0.0328 18.78
ENSOARG00000003744 HP 0.0030 32.45 0.4915 2.36
ENSOARG00000008959 SLIT1 0.0067 26.06 0.0592 10.58
ENSOARG00000013805 COLCA2 0.0004 24.97 0.0036 14.46
ENSOARG00000001869 TREM1 0.0002 23.87 0.0099 8.25
ENSOARG00000009963 SAA3 0.0002 23.74 0.0021 11.79
ENSOARG00000009344 FABP4 0.0002 23.05 0.0131 6.04
ENSOARG00000007086 FCRL2 0.0337 21.38 0.3128 5.10
ENSOARG00000010231 MX2 0.0310 20.40 0.0520 17.18
ENSOARG00000007488 SPTA1 0.0102 − 9.94 0.0259 − 4.37
ENSOARG00000013263 RNASE6 0.0314 − 10.83 0.0210 − 12.29
ENSOARG00000003612 ABCC8 0.0005 − 10.95 0.0075 − 3.09
ENSOARG00000015144 SERPINA5 0.0020 − 11.12 0.0024 − 12.31
ENSOARG00000004611 CCL7 0.0063 − 11.18 0.0087 − 6.05
ENSOARG00000001188 SBK3 0.0003 − 11.33 0.0011 − 8.79
ENSOARG00000016974 KRT5 0.0106 − 11.65 0.0235 − 6.09
ENSOARG00000010570 TMEM213 0.0208 − 12.57 0.0871 − 3.01
ENSOARG00000003570 LGI1 0.0010 − 13.27 0.0035 − 5.66
ENSOARG00000008224 DAB1 0.0026 − 13.78 0.0036 − 11.53
ENSOARG00000020292 MUC4 0.0073 − 14.85 0.0360 − 5.45
ENSOARG00000018133 CFTR 0.0054 − 15.95 0.0270 − 4.72
ENSOARG00000007787 FCER1A 0.0033 − 21.36 0.0493 − 3.72
ENSOARG00000014689 TPSAB1 0.0009 − 22.24 0.0032 − 5.21
ENSOARG00000003456 TH 0.0002 − 24.73 0.0031 − 5.19
ENSOARG00000015746 RIMBP2 0.0004 − 26.13 0.0028 − 7.02
ENSOARG00000008753 GUCY1B2 0.0356 − 29.89 0.2217 − 5.10
ENSOARG00000010016 GPR143 5.1E-05 − 35.25 0.0001 − 33.27
ENSOARG00000005274 CPA3 0.0002 − 41.73 0.0054 − 6.63
ENSOARG00000020992 HDC 8.9E-05 − 54.25 0.0018 − 10.60
Table 1.  Genes up-regulated and down-regulated in the ICLN of multibacillary sheep.  The twenty most 
significantly (adjusted p-value ≤ 0.05) increased and decreased genes, ranked by fold change (FC).
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(+ 4.30 fold) and the IL2 receptor genes, IL2RA, IL2RB and IL2RG were largely unaffected, as were CD2 and 
CTLA4 and the memory T cell markers CCR6 and CD44. The expression of molecules associated with cytotoxic 
T cells and NK cells was variable; the granzymes GZMK (− 3.23 fold) and GZMM (− 1.65 fold) were significantly 
down-regulated, GZMA was increased (+ 2.23 fold) and the cytolytic protein PRF1 was unchanged (Fig. 2).
The expression of T cell associated genes in P sheep was either unchanged or slightly repressed, with fold 
changes less than in M sheep (Fig. 2). One notable difference between the two datasets was IFNG, not significantly 
affected in M but increased in P (+ 2.72 fold).
Disease-associated changes to the B cell and macrophage transcriptomes. The immunoglobu-
lin heavy chains IGHG1 (M, + 16.65 and P, + 15.62 fold), IGHE (M, + 11.89 and P, + 13.25 fold) and IGHA1 (M, 
+ 6.42 and P, + 3.79 fold) were significantly up-regulated in both M and P sheep but IGHD was unaffected in both 
(Fig. 3). We have no information on IGHM, it had been assigned to an ‘unplaced scaffold’ (Scaffold JH921924.1: 
50,045–53,838) in OAR3.1 so transcripts were not mapped. The IGK and IGL light chains in both datasets were 
also increased (average M, + 7.47 and P, + 8.09 fold) as was JCHAIN (M, + 5.41 and P, + 4.35 fold) and MZB1 
Ensembl id Gene
P-value FC P-value FC
Pauci vs control Multi vs control
ENSOARG00000016105 PROC 0.0010 67.62 0.0010 35.20
ENSOARG00000000450 S100A8 0.0253 49.01 0.0025 179.69
ENSOARG00000000432 S100A12 0.0188 27.02 0.0012 99.72
ENSOARG00000012259 FMO3 0.0085 19.77 0.0184 11.55
ENSOARG00000016677 MGAT3 0.0068 18.48 0.0031 19.35
ENSOARG00000009608 RNF186 0.0328 16.75 0.0056 33.48
ENSOARG00000009143 IGHG1 0.0014 15.62 0.0006 16.65
ENSOARG00000013805 COLCA2 0.0036 14.46 0.0004 24.97
ENSOARG00000012509 IGLV9–49 0.0117 14.43 0.0463 6.79
ENSOARG00000010953 XDH 0.0355 14.07 0.0007 84.49
ENSOARG00000008994 IGHE 0.0097 13.25 0.0109 11.89
ENSOARG00000012585 IGLC1 0.0006 12.24 0.0002 14.84
ENSOARG00000001593 CFAP74 0.0029 11.86 0.0020 3.74
ENSOARG00000009963 SAA3 0.0021 11.79 0.0002 23.74
ENSOARG00000013171 C21orf58 0.0053 11.08 0.9875 1.02
ENSOARG00000012537 IGLV1-51 0.0030 11.07 0.0016 12.66
ENSOARG00000003300 DPEP2 0.0012 10.67 0.0002 13.08
ENSOARG00000004536 RPL17 0.0072 10.26 0.0001 56.06
ENSOARG00000012457 IGLV1-50 0.0006 10.25 0.0001 12.92
ENSOARG00000012343 IGLV8-61 0.0044 10.22 0.0016 11.54
ENSOARG00000004611 CCL7 0.0087 − 6.05 0.0063 − 11.18
ENSOARG00000016974 KRT5 0.0235 − 6.09 0.0106 − 11.65
ENSOARG00000000778 MET 0.0024 − 6.38 0.0036 − 4.86
ENSOARG00000018446 PTPRZ1 0.0120 − 6.54 0.0147 − 6.62
ENSOARG00000005274 CPA3 0.0054 − 6.63 0.0002 − 41.73
ENSOARG00000011529 ZFR2 0.0002 − 6.70 0.0001 − 9.79
ENSOARG00000015746 RIMBP2 0.0028 − 7.02 0.0004 − 26.13
ENSOARG00000009731 RGS13 0.0174 − 7.12 0.0206 − 7.34
ENSOARG00000015393 RASSF9 0.0020 − 7.18 0.0113 − 3.27
ENSOARG00000017420 GLI3 0.0007 − 7.21 0.0007 − 5.62
ENSOARG00000000744 LAMC2 0.0095 − 7.97 0.0229 − 5.07
ENSOARG00000014271 MOXD1 0.0004 − 8.05 0.0043 − 2.65
ENSOARG00000001188 SBK3 0.0011 − 8.79 0.0003 − 11.33
ENSOARG00000006864 FCAMR 0.0128 − 8.85 0.0160 − 8.79
ENSOARG00000020992 HDC 0.0018 − 10.60 8.9E-05 − 54.25
ENSOARG00000008224 DAB1 0.0036 − 11.53 0.0026 − 13.78
ENSOARG00000013263 RNASE6 0.0210 − 12.29 0.0314 − 10.83
ENSOARG00000015144 SERPINA5 0.0024 − 12.31 0.0020 − 11.12
ENSOARG00000018455 OLFM3 0.0014 − 15.18 0.0117 − 4.26
ENSOARG00000010016 GPR143 0.0001 − 33.27 5.1E-05 − 35.25
Table 2.  Genes up-regulated and down-regulated in the ICLN of paucibacillary sheep. The twenty most 
significantly (adjusted p-value ≤ 0.05) increased and decreased genes, ranked by fold change (FC).
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(M, + 12.46 and P, + 6.34 fold). Other activated B cell and plasma cell markers were also raised in both infected 
groups, including SDC1 (M, + 4.52 and P, + 5.93 fold). The expression levels of non-activated and memory B cell 
molecules were marginally-repressed or unaffected by MAP infection including the CD79A and CD79B compo-
nents of the B cell antigen receptor, CD19 and MS4A1 (average M, − 1.56 and P, + 1.10 fold). Expression level of 
the costimulatory protein CD40, constitutively expressed by antigen presenting cells, was marginally repressed in 
M sheep (− 1.65 fold) but unchanged in P sheep.
Expression levels of macrophage-associated transcripts was variable in both disease forms, illustrated by two 
scavenger receptors; CD163 (M, + 33.82 and P, + 4.56 fold) and CD68 (M, + 1.88 and P, + 1.32 fold). However, 
other common macrophage markers were unchanged including IL10, CSF1R and ADGRE1. Variation also 
occurred with Fc receptors, FCAMR (M, − 8.79 and P, − 8.85 fold) was repressed and FCGR1A (M, + 6.29 and P, 
+ 3.1 fold) was increased, in both infected groups. There were twenty MHC class II genes identified in both data-
sets with Ovar-DYA significantly repressed (M, − 5.62 and P, − 3.42 fold) in both although the other MHC genes 
were largely unaffected (see Supplementary Table S3).
Inflammation-associated canonical pathways linked with paratuberculosis pathologies. At 
least nine of the top twenty canonical pathways in M sheep were associated with the inflammation and tissue 
repair (Fig. 1); and eleven in P sheep (see Supplementary Figure S3). Approximately equal numbers of genes in 
these pathways were increased and repressed in both datasets. ‘Hepatic Fibrosis/Hepatic Stellate Cell Activation’ 
was the most significant inflammation/tissue repair pathway identified in both datasets. There were twelve matrix 
metalloproteinases in each dataset, most were unaffected but MMP9 (− 4.95 and − 5.37 fold) was repressed in 
both M and P. The inflammation pathways ‘LXR/RXR Activation’, ‘Granulocyte Adhesion and Diapedesis’, ‘Acute 
Phase Response’ and ‘Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis’ were also com-
mon to the two datasets.
The common mediators of acute inflammation IL1B, TNF and LTA were unchanged or slightly repressed in 
both pathologies (average M, − 1.90 and P, − 1.13 fold), while IL1A was not significantly changed in M but was 
up-regulated in P (+ 2.52 fold). In contrast, mediators or indicators of chronic inflammation were significantly 
raised in both M and P, including IL6 (M, + 10.03 and P, + 2.07 fold), CSF3R (M, + 20.23 and P, + 5.43 fold), 
DPEP2 (M, + 13.08 and P, + 10.67 fold) and DPEP3 (M, + 11.86 and P, + 8.22 fold). Anti-inflammatory genes 
like PROC (+ 35.2 and + 67.62 fold) and IL1R2 (+ 8.46 and + 3.83 fold) were also significantly increased in both 
pathologies.
Figure 1. Pathway Analysis of Differentially Expressed Genes of the ICLN in Multibacillary 
Paratuberculosis. The top twenty canonical pathways enriched for differentially expressed genes identified 
in the M versus C dataset are displayed along the y-axis, the significance values (shown in brackets) were 
calculated by Fisher’s exact test right-tailed in IPA. The percentage of differentially expressed genes down-
regulated and up-regulated within each canonical pathway are shown on the x-axis. The total number of genes 
in a pathway is displayed to the right of each of the stacked bars. (* in Rheumatoid Arthritis).
www.nature.com/scientificreports/
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Cell communication/adhesion pathways linked with paratuberculosis. Other significant canon-
ical pathways identified in the M dataset were ‘Communication between Innate and Adaptive Immune Cells’ 
and ‘Granulocyte Adhesion and Diapedesis’, which was also identified in the P dataset, with an almost equal 
Figure 2. Heatmap of paratuberculosis associated changes to the T cell transcriptome. Heatmap profile of 
identified TCR/CD3 and other T cell associated genes expressed in the ICLN of diseased and control sheep. The 
colour key indicates the direction of changes, with red depicting genes up-regulated and blue showing genes 
down-regulated. The colour represents log2 counts per million for each sample, centred and scaled for each row.
Figure 3. Heatmap of paratuberculosis associated changes to professional antigen presenting cell and mast 
cell transcriptome. Heatmap profile of identified TCR/CD3 and other T cell associated genes expressed in the 
ICLN of diseased and control sheep. The colour key indicates the direction of changes, with red depicting genes 
up-regulated and blue showing genes down-regulated. The colour represents log2 counts per million for each 
sample, centred and scaled for each row.
www.nature.com/scientificreports/
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split between up-regulated and down-regulated genes. Sixteen chemokines and chemokine receptors were sig-
nificantly differentially expressed in M and nine in P sheep, but with no obvious expression pattern. CCL15 (M, 
+ 20.39 and P, + 5.9 fold), CCL3 (M, + 4.29 and P, + 3.54 fold) and CCR10 (M, + 8.83 and P, + 4.74 fold) were 
up-regulated, but CCL7 (M, − 11.18 and P, − 6.05 fold) was down-regulated in both pathologies. CXCR1 (+ 6.55 
fold) was raised, and CCR9 (− 4.5 fold) and CCR7 (− 3.59 fold) was repressed in M but unaffected in P. CXCL11 
was significantly increased (+ 5.52 fold) in P but unaffected in M.
Disease-associated changes to the transcription regulators. Many transcription regulators that 
control lymphocyte maturation and differentiation were significantly affected in both disease forms. The core reg-
ulators of T cell and innate lymphoid cell (ILC) maturation, TCF7 (M, − 5.21 and P, − 2.30 fold), LEF1 (M, − 4.62 
and P, − 1.8 fold) and BCL11B (M, − 5.46 and P, 2.78 fold), were repressed in M and P with higher fold changes 
in M (Fig. 2). GATA3, a master regulator of Th2 and ILC2 development, was significantly down-regulated in M 
(− 2.35 fold) but unchanged in P. The master regulators of Th1 and Treg cells, TBX21 and FOXP3, were unaffected 
in both; and the master regulator of Th17, RORC2, was unchanged in M but increased in P (+ 2.25 fold).
The core upstream regulators of B cell maturation, activation and memory development PAX5 (M, − 6.60 and 
P − 4.35 fold), BACH2 (M, − 6.92 and P, − 4.01 fold), AICDA (M, − 6.59 and P, − 5.98 fold) and BCL6 (M, − 1.43 
and − 1.5 fold) were all significantly repressed in both pathologies (Fig. 3). In contrast, three transcription reg-
ulators of plasma cell differentiation were significantly raised, XBP1 (M + 4.94 and P, + 3.25 fold), PRDM1 (M, 
+ 3.06 and + 2.21 fold) and IRF4 (M, + 2.21 and P, + 1.57 fold).
Validation of differential expression by quantitative real-time RT-PCR. Validation of the 
TruSeq data was by RT-qPCR with the Inflammatory Cytokine and Receptors RT2 Profiler PCR array (see 
Supplementary Table S4). There was a significant correlation with diseased cases compared to C (Spearman’s rs 
0.49, p (two-tailed) < 0.0001).
Discussion
The primary aim of this study was to characterize the immune and inflammatory responses of M and P paratuber-
culosis in sheep, focussing on the nature of the immune dysfunction21,28–31 associated with the M disease. TruSeq 
analysis was used to quantify transcripts expressed in the ICLN of diseased (M and P) and uninfected C animals. 
The ICLN was chosen as it is the organ of induction of the immune response for the terminal ileum, a major loca-
tion of paratuberculosis lesions. The disease-associated response within the ICLN is likely to play a major role in 
the development of disease pathology. Analysis of the transcriptome at this strategic immunological site allowed 
an understanding of the immunological response to infection. This enabled the identification of physiological 
pathways and genes associated with the development and maintenance of the paratuberculosis phenotypes.
In M sheep, nine of the most up-regulated genes (Table 1) were associated with chronic rather than acute 
inflammation. PTX3 is an acute phase protein of the lectin pathway of complement and a regulator of inflam-
mation induced by mycobacterial lipoarabinomannan41; polymorphisms of PTX3 are linked with pulmonary 
tuberculosis42. S100A8 and S100A12 are major pro-inflammation mediators43, that play significant roles in 
chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease (IBD)44. S100A8 
is also prominent in lepromatous leprosy45 but with low anti-microbial activity. However, S100A12 can kill 
Mycobacterium leprae and Mycobacterium tuberculosis, although it is more highly expressed in tuberculoid 
leprosy46. XDH plays a major role in phagocytic killing47 and high expression levels are indicative of activated 
and infected macrophages in M paratuberculosis and is characteristic of oxidative stress. VNN1 is involved in 
cysteamine production, a major promotor of inflammation48 and polymorphisms of human VNN1 are linked 
to susceptibility to IBD49. FGF23 is expressed by activated macrophages, and elevated levels impair neutrophil 
recruitment50. The high levels of FGF23 expression and significant repression of its neutrophil receptor FGFR2 
in M and P animals (M, − 5.18 and P, − 2.97 fold) is consistent with the low numbers of neutrophils seen in M 
pathology51. The presence of activated and infected macrophages in the ICLN of M animals is also indicated by 
high expression levels of CD163, which is also up-regulated in a range of chronic inflammatory diseases52. It is a 
scavenger receptor for the haemoglobin/haptoglobin complex and a major effect of receptor/ligand interaction is 
the stimulation of IL-6 production, the major cytokine mediator of the acute phase response53. The link between 
RNF186 and chronic inflammation originates from genome-wide association studies of IBD; overexpression 
of RNF186 is indicative of endoplasmic reticulum stress and a truncated variant of RNF186 confers protection 
against ulcerative colitis54,55. These genes were also up-regulated in P sheep, but with lower fold changes. Of these 
genes only VNN1 (M, + 40.23 and P, + 2.27 fold) is significantly different between M and P.
The most repressed transcripts in M sheep include four genes associated with mast cell function and may 
indicate a marked reduction in mast cells numbers in infected ICLN. HDC is the most down-regulated gene in 
the M dataset and encodes an enzyme that synthesizes histamine, a major component of mast cell granules56. Its 
importance in mycobacterial infection is highlighted by the greatly increased growth of Mycobacterium bovis 
BCG in macrophages from HDC −/− knock-out mice; addition of histamine to HDC−/− macrophages decreased 
the numbers of intracellular bacilli57. CPA3 and TPSAB1 encode proteases that are major constituents of mast 
cell granules and play important roles in the control of chronic inflammation and in regulating sepsis58. FCER1A 
encodes the high affinity IgE receptor alpha chain that is essential for mast cell interactions with antigen56. In 
addition, transcripts for mast cell growth factor KITLG and its receptor KIT are also repressed in infected animals. 
Mast cells play a significant role in the homeostasis of immune responses59,60 and the marked reduction of mast 
cell numbers/function in the ICLN may negatively influence myeloid DC activation and function, evidenced by 
the repression of the uniquely ruminant MHC class II transcript Ovar-DYA, which is exclusively expressed by 
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DC61. These results, and the preliminary histological observations, highlight the need to more accurately charac-
terize mast cells in the ICLN and investigate their role in paratuberculosis pathology.
The ICLN drains the M lesions in the terminal ileum, which contain large numbers of infected mac-
rophages10,11. Lymph nodes that drain sites of infection are usually hypertrophic and their constituent lympho-
cytes are highly activated62. This activation is reflected here by the significant increase in the activation marker 
CD70; this may reflect activated B cells as most of the genes associated with T cell activation and signal transduc-
tion were significantly repressed. This down-regulation includes the TCR and CD3 clusters, most co-receptor 
and co-stimulatory molecules as well as members of signal transduction pathways. Antigen activation in sheep 
leads to a increases in MHC class II63 by T cells but in M sheep MHC class II expression levels (except Ovar-DY) 
were largely unaffected. In addition, MHC class II expression by macrophages was not significantly affected; 
which may be linked to the fact that IFNG levels were not significantly raised in M animals. Sheep with M disease 
express reduced levels of IFNG in MLN compared to subclinically infected animals64, which possibly results in 
uncontrolled MAP growth. IFNG levels are raised in P animals, which have few mycobacteria. The repression of 
T cell transcripts in M animals may be due to a reduction in T cell numbers, although the expression levels of 
genes that encode common T cell markers (e.g. CD2) is unchanged. One possible explanation for the depressed 
T cell response in M sheep could be that chronic bacterial infections, including Mycobacterium tuberculosis, trig-
ger a programmed down-regulation of high avidity TCR65. This results in the reduction of TCR expression and 
T cell activation, but is hypothesized to preserve the polyclonality of the immune response and protect against 
immune-mediated inflammatory damage65.
After encountering antigen, B cells differentiate into plasma cells through a tightly organised gene-expression 
programme controlled by specific transcriptional regulators66. The up-regulation of immunoglobulin transcripts 
in M and P sheep is consistent with B cell activation, class switching and terminal differentiation into plasma 
cells (Fig. 3). Also required for Ig heavy chain biosynthesis is MZB167, which is up-regulated in infected animals. 
However, molecules associated with resting or memory B cells were reduced or unchanged including the B cell 
co-receptor complex (CR2, CD19 and CD81), BCR signal transduction heterodimer (CD79A and CD79B) and 
MS4A1 (CD20). The plasma cell transcriptional regulators, IRF4, PRDM1 and XBP1 were raised while those 
required for mature B cell maintenance, PAX5, BACH2, AICDA and BCL666 were repressed or unchanged in M 
and P sheep. High levels of PRDM1 (Blimp1) repress the key regulators of the B cell gene expression programme 
PAX5 and BCL6, thus a plasma cell-specific gene expression programme was maintained. Another key regulator 
of plasma cell differentiation and growth68 is IL-6, which is highly increased in M sheep, it up-regulates XBP1 and 
is itself regulated by XBP169. IL-6 is also a major driver of the acute phase response and chronic inflammation68. It 
is not significantly affected in P disease. High anti-MAP antibody levels is a common finding in M paratuberculo-
sis11 and has also been described in human mycobacterial diseases, but their role in disease pathogenesis remains 
unclear70. As with inflammation and T cell genes, the expression patterns of these genes in P sheep is similar to M 
sheep, but usually with lower fold changes.
Communication between individual components of the innate and adaptive immune systems, highlighted by 
IPA analysis, is essential for the control and/or elimination of pathogens71. In M animals there is little consist-
ency in chemokine/chemokine receptor expression. CCL15, CCL3 and CXCR1 influence T cell, monocyte and 
neutrophil migration and are significantly increased in M and P animals; as is CCR10, which plays a critical role 
in humoral immunity at mucosal sites71. However their respective ligands/receptors are either unaffected or not 
identified in the datasets. CCL7 also influences monocyte and lymphocyte mobilization but is repressed in both M 
and P; while CCR9 controls T cell homing to the gut, and is down-regulated only in M. As with the up-regulated 
chemokines, their respective ligands/receptors are also unaffected. The only receptor/ligand pair that shows con-
sistent expression is CXCR3/CXCL10 in M animals, which control Th1 mediated T cell migration71.
The primary aim of this study was to begin to describe the basis of the immune dysfunction associated with M 
paratuberculosis. Lymph nodes draining the site of bacterial infections should show extensive evidence of T cell 
activation, acute inflammation and antibody synthesis. However, TruSeq analysis of the ICLN, the major immune 
inductive site of paratuberculosis lesions, showed that T cells were not activated, the T cell antigen-receptor 
complex genes (TCR and CD3) were all down-regulated or unaffected, as were most of the T cell co-receptor and 
co-stimulator transcripts, many T cell activation molecules and most of the signal-transduction cascade. There 
was clear evidence of inflammation in the ICLN draining the both M and P lesions, but this was clearly an acute 
phase response and chronic inflammation, with little evidence of acute inflammation. The high levels of immuno-
globulin transcripts is consistent with the anti-MAP antibody responses frequently reported in M sheep, however 
similar high levels of immunoglobulin transcripts were also identified in P sheep, even though few bacteria can 
be detected and antibody levels are inconsistent. Also seen in M and P sheep was the repression of transcripts 
associated with resting and memory B cells. However, perhaps the most novel observation of these studies was 
the profound reduction in mast cell transcripts in both disease forms. This may negatively influence the acti-
vation state of myeloid DC, which are known to play a major role in the induction of the immune response. In 
conclusion, M and P diseases are two different pathologies, but this study shows that there were no fundamental 
differences in the gene expression patterns in M and P disease. There was no shift in T cell genes from a Th1 to 
Th2 pattern in P and M sheep, rather there was an incremental decline in the expression of T cell genes and an 
increase in the expression of chronic inflammation genes, eventually leading to the immune dysfunction associ-
ated with multibacillary pathology.
Materials and Methods
Animals and sample collection. Diseased sheep were out bred Scottish Blackface or Blackface X ewes 
with naturally-acquired MAP infection originating from local commercial flocks (see Supplementary Table S1). 
Uninfected control animals were all healthy Blackface sheep from a flock with no history of paratuberculosis, 
with no clinical disease or pathology. All animals were 2 to 4.5 years old, with no/low gastrointestinal nematode 
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infection and none had been vaccinated against Johne’s disease. At post mortem the ICLN, distal MLN, ileocaecal 
valve and terminal ileum adjacent to the ileocaecal valve were collected and were fixed in 10% neutral buffered 
formalin for histopathology. Adjacent segments of terminal ileum (2 cm) were stored at − 80 °C for subsequent 
detection of MAP growth. The ICLN was treated with RNAlater RNA Stabilization Solution (Ambion) and stored 
at − 80 °C prior to RNA extraction (according to manufacturer’s instructions). No sheep were euthanized specif-
ically for this work, uninfected sheep were euthanized for unrelated reasons and infected animals were culled for 
clinical reasons.
Pathological Diagnosis, Histopathology and Bacteriology. Formalin fixed tissues from MLN and 
terminal ileum were paraffin blocked and 5 μ m sequential sections were stained with H&E, ZN or toluidine blue. 
All histopathology observations were described by a qualified veterinary pathologist (FC). The pathological diag-
nosis was evaluated and scored as described by Dennis et al. with modifications72. Frozen segments of terminal 
ileum were cultured for the subsequent detection of MAP growth on slopes of 7H1173. Colonies were confirmed 
as MAP using a standardized IS900 PCR (see Supplementary Table S1).
Nucleic acid isolation. Genomic DNA was extracted from ~20 mg (wet weight) ICLN for each sample using 
the Wizard® SV Genomic DNA Purification System (Promega) as described by the manufacturer and quantified 
using a NanoDrop ND-1000 spectrophotometer. For RNA isolation ICLN was disrupted and homogenized in 
a Lysing Matrix D tube (MP Biomedicals), containing ~40 mg of tissue and 1 ml of TRIzol reagent (Ambion), 
using a FastPrep FP120 Cell Disrupter (Thermo Electron). Total RNA was extracted using a TRIzol ® Plus RNA 
Purification Kit (Ambion) as described by the manufacturer, including DNase I treatment. RNA quality and 
integrity were assessed using an Agilent RNA ScreenTape on the Agilent 2200 TapeStation and quantified using a 
NanoDrop ND-1000 spectrophotometer. All samples had RIN values > 7.5.
Detection of MAP by IS900 PCR. The presence of MAP in the ICLN was assessed by PCR using two 
previously validated primer sets: Eishi IS900 primer forward74; GTTCGGGGCCGTCGTTAGG; reverse; 
GCGGGCGGCCAATCTCCTT: and Bauerfeind MP3 primer75; CTGGCTACCAAACTCCCGA; MP4; 
GAACTCAGCGCCCAGGAT. All PCR reactions were performed with FastStart Taq DNA Polymerase (Roche 
Diagnostics) following manufacturer’s instructions, with 500 ng of gDNA and 0.2 μ M of each primer. PCR reac-
tions were performed using a Veriti® Thermal Cycler (Applied Biosystems); conditions were an initial denatur-
ation step of 5 min at 95 °C, followed by 35 cycles of 15 sec at 95 °C, 15 sec at 55 °C, 58 °C, 60 °C or 62 °C, 30 sec at 
72 °C, with a final elongation step of 10 min at 72 °C. PCR products were fractionated by 2% agarose gel electro-
phoresis, purified with MinElute Gel Extraction Kit (Qiagen), cloned using a TOPO TA cloning kit for sequenc-
ing (Invitrogen), and sequenced using BigDye® Terminator v3.1 Cycle Sequencing Kit and 3730 DNA Analyser 
(Applied Biosystems), according to the manufacturer’s instructions.
TruSeq library construction, sequencing and data processing. Template cDNA libraries for each 
sample were constructed using TruSeq™ RNA Sample Preparation Kit v2 according to the manufacturer’s instruc-
tions (Illumina). The cDNA libraries were sequenced from both ends (2 × 101-nucleotide paired-end reads) using 
an Illumina HiSeq 2500 sequencing system at Edinburgh Genomics (University of Edinburgh, UK) according to 
the manufacturer’s protocol. All sequence and metadata have been deposited in the ArrayExpress database (www.
ebi.ac.uk/arrayexpress) under accession number E-MTAB-5146.
Prior to alignment, read sequence quality and composition were checked using FastQC (v0.10.1) software 
then processed using Cutadapt v1.376 program for adapter and quality trimming. Using STAR (v2.3)77 software 
sequencing reads were aligned to the Ovis aries genome (Oar v3.1, GCA_000298735.1). The SAM files of the 
mapped reads were processed and organized using utilities from SAMtools78 prior to summarization of the read 
counts at the gene level using the script htseq-count(v0.6.1p1) of the Python package HTSeq79. Filtering of genes 
was performed to retain only those that had at least 1 count per million mapped reads, in at least five samples for 
further analysis.
Differential expression analysis of gene expression data. Filtered gene read counts were normalized 
using TMM scaling method80 before voom transformation81 with sample-specific quality weights applied before 
linear model analysis to assess differential gene expression with the limma package in R82. Gene names and sym-
bols were retrieved for differentially expressed genes from Ensembl, annotation release 86, using the biomaRt 
package83. Manual annotation of unannotated genes of interest was performed using BLASTN analysis84.
Causal Network Analysis, Molecular Network and Pathway analysis. The differentially expressed 
genes datasets were analysed, by uploading the HUGO Gene Nomenclature Committee (HGNC) gene symbols 
for the sheep orthologues, fold change data and adjusted P-values, through the use of QIAGEN’s Ingenuity® 
Pathway Analysis (IPA® , QIAGEN Redwood City, www.qiagen.com/ingenuity). Overrepresented canonical path-
ways were identified, which, in addition to identifying enriched biological functions, pathway activity analysis 
allowed prediction of the activation status for each pathway using the activation z-score algorithm.
Inflammatory cytokines & receptors RT2 profiler™ PCR array. The Cow Inflammatory Cytokines 
& Receptors RT2 Profiler™ PCR Array (Qiagen) was used for the quantitative real-time RT-PCR (RT-qPCR) anal-
ysis of the ICLN of all sheep. Total RNA was extracted as described above and each sample of RNA was reverse 
transcribed using a RT2 First Strand Kit according to the manufacturer’s protocol (Qiagen). Real-time PCR was 
performed on each cDNA sample using the RT2 Profiler™ PCR Array with the RT2 SYBR Green/ROX FAST 
Mastermix in a Rotor-Gene Q cycler (Qiagen). The cycling profile was performed at 95 °C for 10 min, 40 cycles of 
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95 °C for 15 s and 60 °C for 1 min. Melting curve analysis of qPCR products confirmed the absence of secondary 
product. RT2 Profiler PCR Array Data Analysis version 3.5 software (http://pcrdataanalysis.sabiosciences.com/
pcr/arrayanalysis.php) was used for data analysis. Spearman rank-order correlation analysis was carried out using 
GraphPad Prism 6.07 for Windows (GraphPad Software, La Jolla California USA, www.graphpad.com).
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